Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant MS4A1 (Obinutuzumab Biosimilar) antibody

Research Grade Reactivity: Human ELISA Host: Mammalian Cells Monoclonal unconjugated Recombinant Antibody
Catalog No. ABIN7487892
  • Target
    MS4A1 (Obinutuzumab Biosimilar)
    Antibody Type
    Recombinant Antibody
    Reactivity
    Human
    Host
    • 1
    Mammalian Cells
    Expression System
    Mammalian cells
    Clonality
    • 1
    Monoclonal
    Conjugate
    • 1
    This MS4A1 (Obinutuzumab Biosimilar) antibody is un-conjugated
    Application
    ELISA
    Purpose
    Obinutuzumab Biosimilar - Anti-MS4A1, CD20 mAb
    Characteristics
    Antibody Type: IgG1-kappa
    Purification
    Recombinant antibody expressed in mammalien cells and purified.
    Grade
    Research Grade
    Isotype
    IgG1 kappa
  • Restrictions
    For Research Use only
  • Buffer
    PBS pH 7.5
    Storage
    -80 °C
    Storage Comment
    store at -80°C
  • Target
    MS4A1 (Obinutuzumab Biosimilar)
    Target Type
    Biosimilar
    Background
    GA101,RG7159,RO5072759,afutuzumab
    Obinutuzumab is a humanized monoclonal antibody that can be used in combination with chlorambucil to treat chronic lymphocytic leukemia. It was sold under the Gazyva brand. There are black box warnings of fatal hepatitis B virus (HBV) reactivation and fatal progressive multifocal leukoencephalopathy (PML).
    CAS-No
    949142-50-1
You are here:
Support